PRESBYOND can sometimes be performed in stable, well‑controlled autoimmune disease, but active or severe disease often makes laser unsuitable.
Risks in autoimmune conditions
Healing and inflammation can be unpredictable.
- Higher risk of dry eye, delayed healing, or inflammatory complications
- Some systemic treatments alter infection or wound‑healing responses
- Conditions such as Sjögren’s markedly affect the ocular surface
- Flare‑ups may worsen ocular symptoms around the time of surgery
- Outcome variability is greater than in otherwise healthy patients
When it may still be considered
Requires multidisciplinary planning.
- Stable disease with minimal ocular involvement
- Clear potential benefit and strong patient motivation
- Coordination with rheumatologist regarding timing and medication cover
- Acceptance of higher uncertainty and need for close follow‑up
- In many cases, lens‑based or non‑surgical options are preferred
